Investigation of genotoxicity risk and DNA repair capacity in breast cancer patients using anastrozole

OBJECTIVE: Breast cancer is the most common cancer in women worldwide and the incidence increases in postmenopausal women. Anastrozole is a non-steroidal (type II), third-generation aromatase inhibitor (AI) that is used in the treatment of postmenopausal estrogen-related breast cancer. Several studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tugce Yesil, Devecioglu, Aydogan, Fatih, Omurtag, Gulden Zehra, Bese, Nuran Senel, Sardas, Semra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864710/
https://www.ncbi.nlm.nih.gov/pubmed/29607425
http://dx.doi.org/10.14744/nci.2017.55822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864710/
https://www.ncbi.nlm.nih.gov/pubmed/29607425
http://dx.doi.org/10.14744/nci.2017.55822

Ejemplares similares